Document Detail

Long-Acting Poly(DL:Lactic Acid-Castor Oil) 3:7-Bupivacaine Formulation: Effect of Hydrophobic Additives.
MedLine Citation:
PMID:  21717256     Owner:  NLM     Status:  Publisher    
PURPOSE: To reduce formulation viscosity of bupivacaine/poly(DL lactic acid co castor oil) 3:7 without increasing bupivacaine release rates. METHODS: Poly(DL lactic acid) 3:7 was synthesized and bupivacaine formulation prepared by mixing with additives ricinoleic acid or castor oil. In vitro release measurements identified optimum formulation. Anesthetized ICR mice were injected around left sciatic nerve using nerve stimulator with 0.1 mL of formulation. Animals received 10% bupivacaine-polymer formulation with 10% castor oil (p(DLLA:CO)3:7-10% bupi-10% CO) or 15% bupivacaine-polymer with 10% castor oil (p(DLLA:CO)3:7-15% bupi-10% CO). Sensory and motor block were measured. RESULTS: Viscosity of 10% and 15% bupivacaine-p(DLLA:CO)3:7 formulations was reduced using hydrophobic additives; however, castor oil reduced bupivacaine release rates and eliminated burst effect. Less than 10% of the incorporated bupivacaine was released during 6 h, and less than 25% released in 24 h in vitro. In vivo formulation injection resulted in a 24 h motor block and a sensory block lasting at least 72 h. CONCLUSIONS: Incorporation of hydrophobic low-viscosity additive reduced viscosity in addition to burst release effects. Bupivacaine-polymer formulation with castor oil additive demonstrated prolonged sensory analgesia in vivo, with reduced duration of motor block.
Marina Sokolsky-Papkov; Ludmila Golovanevski; Abraham J Domb; Carolyn F Weiniger
Related Documents :
6725476 - Determination of glycosylated haemoglobin by isoelectric focusing in non-linear ph grad...
1569046 - Studies on the uronic acid-containing glycoproteins of fusarium sp. m7-1: i. isolation ...
22285266 - Amelioration of cyclophosphamide induced myelosuppression and oxidative stress by cinna...
24128566 - Characterisation of lipid fraction of marine macroalgae by means of chromatography tech...
422496 - Instability of pr toxin in blue cheese.
3227956 - Elevated concentration of 5-hydroxytryptamine in ultrafiltrate of human liver vein plas...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-30
Journal Detail:
Title:  Pharmaceutical research     Volume:  -     ISSN:  1573-904X     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8406521     Medline TA:  Pharm Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Center for Drug Delivery and Nanomedicine Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Durham Research Center, 985830, Omaha, Nebraska, 68198-5830, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Time-Correlated Single Photon Counting For Simultaneous Monitoring Of Zinc Oxide Nanoparticles And N...
Next Document:  Use of the Goldman Technique to Correct Both the Overprojected and the Broad Nasal Tip.